Vinge advises Bridgepoint on the acquisition of Ports Group

August 31, 2023

Vinge is advising Bridgepoint Development Capital ("Bridgepoint") in connection with the acquisition of House of Ports Holding AB ("Ports Group").

Ports Group is a fast growing and profitable platform-based provider of IP and domain services. Ports Group has a unique position in the market with 25 years of experience in digitalisation as an ICANN-accredited registrar and a comprehensive Brand Protection package including software and services within Domain Management, Trademark Management and Web Security. Proactive protection through Ports Group's monitoring services secures the customer's intellectual property and exclusive rights. Central to what Ports offers is the Ports Management software platform, which brings together the portfolio of holdings, providing an optimal overview and automated management. The platform manages domains, trademarks and web security products.

Vinge's team consisted of Daniel Rosvall, Samra Tesser, Ellen Flygt, Michella Lina Said and Elis Allmark (M&A), Louise Brorsson Salomon, Josefine Lanker, Jolinn Uhlin, David Flodin, Nour Makie (Banking and Finance), Mathilda Persson, Mika Jordan and Jolene Reimerson (IT and GDPR), Mario Saad (Commercial), Julia Löfqvist (Compliance), Alexandra Tamm (Real Estate), David Olander (EU and Competition), and Cecilia Loctander (Project Assistant).




Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023